Clinical trial · Interventional
Early Palliative Care in Patient With Acute Leukaemia
Impact on Quality of Life of an Early Management Supportive Care of Patients With Acute Leukemia in First Relapse.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Several studies have shown that patients with acute leukemia have many symptoms during disease These symptoms decrease the quality of life and may even appear or worsen other symptoms such as depression Several studies point to the involvement of supportive care and palliative care is delayed in these patients The aim of this study is to evaluate the impact on the quality of life of an early and standardized involvement of a support / palliative care team for patients with acute leukemia in first relapse compared to a control group .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Leukaemia in Relapse | Acute Leukemia | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Supportive /palliative care intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Supportive /palliative care intervention
- description
- patients will be supported by a multidisciplinary palliative specialist team
- interventionNames
- Other: Supportive /palliative care intervention
- type
- NO_INTERVENTION
- label
- usual medical follow up
- description
- patients will be supported by the support care team if asked by the oncologist
Primary outcomes (1)
- measure
- mesure of quality of life
- timeFrame
- 12 weeks
- description
- Quality of life measured by FACT Leu questionnaire. score of quality of life will be compared between the 2 groups
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * \> 18 years old * acute lymphoblastic or myeloblastic leukemia at first relapse and diagnosed within 8 weeks before inclusion. * Patients in whom a curative strategy (transplant) is not considered. * patients older that 75 years at the diagnosis * informed signed consent Exclusion Criteria: * unable to answer the questionnaire * psychiatric disorders other than depression * persons under guardianship
References
Publications (1)
- RESULTLedoux M, Rhondali W, Lafumas V, Berthiller J, Teissere M, Piegay C, Couray-Targe S, Schott AM, Bruera E, Filbet M. Palliative care referral and associated outcomes among patients with cancer in the last 2 weeks of life. BMJ Support Palliat Care. 2019 Mar;9(1):e16. doi: 10.1136/bmjspcare-2014-000791. Epub 2015 Sep 23. PMID 26399699